William Richard White is CFO at Akero Therapeutics, Inc. (AKRO). They have made 24 open-market trades across 3 companies since 2021, most recently 2025-12-09.
CIK 0001778739
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 24 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| AKRO | SELL | 2025-09-11 | 2025-09-12 | $43.02 | $28K | +9.8% | +24.1% | N/A |
| AKRO | SELL | 2025-06-18 | 2025-06-20 | $54.84 | $179K | -3.3% | -4.2% | -13.9% |
| AKRO | SELL | 2025-06-10 | 2025-06-12 | $54.00 | $151K | +5.5% | +1.0% | -17.1% |
| AKRO | SELL | 2025-03-12 | 2025-03-14 | $44.88 | $30K | -1.9% | -14.8% | +21.3% |
| AKRO | SELL | 2024-12-10 | 2024-12-12 | $30.79 | $173K | +0.0% | -20.7% | +60.6% |
| IRON | SELL · 10b5-1 | 2024-12-02 | 2024-12-04 | $64.61 | $240K | +4.2% | +0.5% | -12.8% |
| IRON | SELL · 10b5-1 | 2024-11-01 | 2024-11-05 | $58.43 | $846K | -10.9% | -6.6% | -17.6% |
| IRON | SELL · 10b5-1 | 2024-10-01 | 2024-10-03 | $51.31 | $10K | -5.4% | +15.6% | +24.0% |
| AKRO | SELL | 2024-09-10 | 2024-09-13 | $26.18 | $17K | +2.2% | +9.5% | +5.9% |
| IRON | SELL · 10b5-1 | 2024-09-03 | 2024-09-05 | $49.55 | $174K | -5.7% | -5.7% | +28.4% |
| AKRO | SELL · 10b5-1 | 2024-08-26 | 2024-08-29 | $27.02 | $5.3M | -4.9% | +6.5% | +19.4% |
| IRON | SELL · 10b5-1 | 2024-08-01 | 2024-08-05 | $43.44 | $9K | +15.5% | +17.8% | +39.3% |
| AKRO | SELL · 10b5-1 | 2024-07-23 | 2024-07-25 | $27.07 | $8.7M | -13.9% | -4.6% | +0.1% |
| AKRO | SELL · 10b5-1 | 2024-07-16 | 2024-07-18 | $28.05 | $2.0M | -2.0% | -4.3% | +14.4% |
| IRON | SELL · 10b5-1 | 2024-07-01 | 2024-07-03 | $46.04 | $9K | +9.0% | -2.6% | +19.9% |
| AKRO | SELL | 2024-06-11 | 2024-06-13 | $22.64 | $128K | -5.2% | +13.4% | +5.9% |
| IRON | SELL · 10b5-1 | 2024-06-03 | 2024-06-05 | $36.09 | $134K | +18.9% | +23.6% | +31.5% |
| IRON | SELL · 10b5-1 | 2024-05-01 | 2024-05-03 | $28.63 | $6K | +6.5% | +21.2% | +44.6% |
| IRON | SELL · 10b5-1 | 2024-04-11 | 2024-04-15 | $31.80 | $160K | -11.8% | +6.0% | +63.8% |
| AKRO | SELL | 2024-03-13 | 2024-03-15 | $28.33 | $21K | -9.3% | -19.4% | -8.6% |
| AKRO | SELL | 2023-12-14 | 2023-12-18 | $20.76 | $13K | +5.8% | -1.3% | +21.6% |
| IRON | SELL | 2023-12-12 | 2023-12-14 | $64.04 | $3.5M | -1.3% | +6.5% | +11.6% |
| AKRO | SELL · 10b5-1 | 2023-09-13 | 2023-09-25 | $50.34 | $32K | +4.0% | -73.9% | -48.0% |
| AKRO | SELL | 2023-06-20 | 2023-06-22 | $55.00 | $1.1M | -12.7% | -16.4% | -5.8% |
| AKRO | SELL · 10b5-1 | 2023-06-13 | 2023-06-15 | $55.16 | $33K | -19.5% | -20.7% | -10.8% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.